Burlingame Asset Management »

Nabi Biopharmaceuticals shares owned by Burlingame Asset Management

Quarter-by-quarter ownership of Nabi Biopharmaceuticals shares owned by Burlingame Asset Management from 13F filings

Historical chart of Burlingame Asset Management investment in Nabi Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nabi Biopharmaceuticals held by Burlingame Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nabi Biopharmaceuticals by Burlingame Asset Management

Quarter filed Position value Share count Share price at filing
2012-06-30 $725k 459k 1.58

More positions owned by Burlingame Asset Management

Pain Therapeutics
FutureFuel (FF)
Nts Inc Nev
TFS Financial Corporation (TFSL)
General Motors Company (GM)
Rambus Inc Del note 5.000% 6/1
Clayton Williams Energy
Wal-Mart Stores (WMT)
Harvest Natural Resources
Wpx Energy
Lone Pine Res
Gyrodyne Company of America
Hilltop Holdings (HTH)
Gap (GAP)
CVR Energy (CVI)

View all positions for Burlingame Asset Management